Paul D’Angio's Insider Trades & SAST Disclosures
Paul D’Angio's most recent trade in Neximmune Inc was a trade of 44,983 Stock Option (right to buy) done . Disclosure was reported to the exchange on July 5, 2023.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Paul D’Angio.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Neximmune Inc | Paul D’Angio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jul 2023 | 44,983 | 44,983 | - | - | Stock Option (right to buy) | |
| Neximmune Inc | Paul D’Angio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 61,678 | 61,678 | - | - | Stock Option (right to buy) | |
| Neximmune Inc | Paul D’Angio | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Apr 2023 | 61,678 | 0 | - | - | Stock Option (right to buy) | |
| Neximmune Inc | Paul D’Angio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 23,122 | 23,122 | - | - | Stock Option (right to buy) | |
| Neximmune Inc | Paul D’Angio | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Apr 2023 | 23,122 | 0 | - | - | Stock Option (right to buy) | |
| Neximmune Inc | Paul D’Angio | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Apr 2023 | 12,634 | 0 | - | - | Stock Option (right to buy) | |
| Neximmune Inc | Paul D’Angio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 12,634 | 12,634 | - | - | Stock Option (right to buy) | |
| Neximmune Inc | Paul D’Angio | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Apr 2023 | 9,556 | 0 | - | - | Stock Option (right to buy) | |
| Neximmune Inc | Paul D’Angio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 9,556 | 9,556 | - | - | Stock Option (right to buy) | |
| Neximmune Inc | Paul D’Angio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2022 | 61,678 | 61,678 | - | - | Stock Option (Right to Buy) | |
| Neximmune Inc | Paul D’Angio | Director | 17 Feb 2021 | 19,627 | 0 | - | - | Series A Preferred Stock | ||
| Neximmune Inc | Paul D’Angio | Director | 17 Feb 2021 | 19,627 | 19,627 | - | - | Common Stock | ||
| Neximmune Inc | Paul D’Angio | Director | 17 Feb 2021 | 4,110 | 23,737 | - | - | Common Stock | ||
| Neximmune Inc | Paul D’Angio | Director | 17 Feb 2021 | 4,110 | 27,847 | - | - | Common Stock | ||
| Neximmune Inc | Paul D’Angio | Director | 17 Feb 2021 | 4,110 | 0 | - | - | Series A2 Preferred Stock | ||
| Neximmune Inc | Paul D’Angio | Director | 17 Feb 2021 | 4,110 | 0 | - | - | Series A3 Preferred Stock | ||
| Neximmune Inc | Paul D’Angio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2021 | 9,556 | 45,312 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges